Long-term data from APPROACH: phase 1/2a randomized, double-blind, placebo-controlled study evaluating safety/tolerability and immunogenicity of vaccine regimens using combinations of Ad26.Mos.HIV, MVA-mosaic and gp140 envelope protein

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Tomaka, F; Stieh, D; Barouch, D; Robb, M; Michael, N; Tomaras, G; Alter, G; McElrath, J; Lavreys, L; Nijs, S; Callewaert, K; Hendriks, J; Euler, Z; Pau, M; Schuitemaker, H

Published Date

  • July 1, 2018

Published In

Volume / Issue

  • 21 /

Start / End Page

  • 2 - 3

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 1758-2652